Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Nurix Therapeutics, Inc. Transaction History
Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group
- $255 Billion
- Q2 2024
A detailed history of Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group holds 85,000 shares of NRIX stock, worth $2.16 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
85,000
Previous 85,000
-0.0%
Holding current value
$2.16 Million
Previous $1.25 Billion
41.97%
% of portfolio
0.69%
Previous 0.49%
Shares
1 transactions
Others Institutions Holding NRIX
# of Institutions
183Shares Held
66.4MCall Options Held
40.9KPut Options Held
106K-
Black Rock Inc. New York, NY6.82MShares$174 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.42MShares$113 Million6.02% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.99MShares$102 Million2.73% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$98.8 Million1.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$92.2 Million0.0% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $1.2B
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...